Ophthalmic Ultrasound Devices Market Size, Share, Growth, and Industry Analysis, By Type (A-Scan Ophthalmic Ultrasound Devices,B-Scan Ophthalmic Ultrasound Devices,Ultrasound Bio Microscope (UBM),Other), By Application (Hospitals,Eye Research Institutes,Ophthalmic Clinics,Other), Regional Insights and Forecast to 2035

Ophthalmic Ultrasound Devices Market Overview

The global Ophthalmic Ultrasound Devices Market is forecast to expand from USD 790.77 million in 2026 to USD 860.52 million in 2027, and is expected to reach USD 1692.12 million by 2035, growing at a CAGR of 8.82% over the forecast period.

The Ophthalmic Ultrasound Devices Market includes diagnostic and imaging systems such as A-scan, B-scan, ultrasound biomicroscopy (UBM), and combined ophthalmic ultrasound platforms used in routine eye care and surgical planning. In 2023, the global ophthalmic ultrasound devices sector was valued at USD 590.9 million, with North America holding 38.0 % share. The A-scan modality generates more than 25 % of device shipments globally. In China, the ophthalmic ultrasound devices market was USD 22.6 million in 2021 and is projected to reach USD 41.5 million by 2028. The hospital end-user segment accounts for > 45 % of total deployments.

In the United States, the ophthalmic ultrasound devices market dominates within North America, contributing about 82.4 % of the region’s revenue in 2023. U.S. ophthalmic centers purchase more than 9 out of 10 of all portable and B-scan systems in North America. Over 2 million cataract surgeries annually in the U.S. rely on ultrasound biometry when optical methods fail. More than 50 % of U.S. academic eye hospitals maintain both UBM and B-scan units. The American market also leads in adoption of advanced multifunction devices combining A-scan, B-scan, and pachymeter modules, present in nearly 30 % of new system orders.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: ~42 % of ocular disease diagnostics currently rely on ultrasound when opacities block optical imaging.
• Major Market Restraint: ~20 % of clinicians avoid ultrasound due to training and user variability concerns.
• Emerging Trends: ~15 % of new devices incorporate AI-assisted segmentation in 2024.
• Regional Leadership: North America held ~38 % share of the ophthalmic ultrasound market.
• Competitive Landscape: Top 5 firms command ~45 % of global installed base share.
• Market Segmentation: A-scan, B-scan, and UBM account for ~70 % of device shipments.
• Recent Development: In 2023–2024, ~6 new portable multi-modal ultrasound systems were launched globally.

Ophthalmic Ultrasound Devices Market Latest Trends

Recent Ophthalmic Ultrasound Devices Market Trends show an accelerated move toward multi-modal and portable devices. In 2024, ~15 % of new device launches combined A-scan, B-scan, and UBM in a single probe head. Adoption of AI-based segmentation and automated measurement is rising: about 10–15 % of new systems now offer auto boundary detection for retina or anterior chamber angles. Compact and handheld form factors account for 20–25 % of new orders in emerging markets. There is a trend toward cloud integration and remote reading—~8 % of units sold include built-in WiFi or network capabilities. Another notable trend is miniaturization of probes, with newest probes reducing weight by 30–40 % compared to earlier generations. Higher frequency probes (50–100 MHz) are seeing increased utilization in anterior segment imaging, making up ~12 % of UBM sales in 2024. In parallel, value bundles (device + service contract + accessories) are now offered in ~35 % of contracts in North America and Europe. Finally, regulatory approval acceleration in Asia is shortening device time to market by ~20 %, increasing regional adoption. These trends are shaping the Ophthalmic Ultrasound Devices Market Outlook toward more intelligent, portable, and integrated systems.

Ophthalmic Ultrasound Devices Market Dynamics

Ophthalmic Ultrasound Devices Market, valued at USD 726.6 million, is projected to reach USD 1,555.3 million by 2034, expanding due to an 8.82 % annual growth trajectory. The market dynamics are driven by rising global eye disease incidence, with over 2.2 billion people affected by vision impairment worldwide, and increasing surgical volumes—approximately 30 million cataract surgeries conducted each year.

DRIVER

"Rising prevalence of ocular diseases and limitations of optical imaging"

One of the principal drivers is the growing incidence of eye disorders—cataract, glaucoma, diabetic retinopathy, retinal detachments—especially in aging populations. When media opacities (e.g. dense cataract, hemorrhage) prevent optical imaging, clinicians rely on ultrasound; approximately 42 % of eye disease assessments require ultrasound assistance. Increasing surgical volumes—for example, cataract surgeries exceed 30 million globally annually—fuel demand for biometry devices. Moreover, the expansion of eye care infrastructure in developing economies has increased new installations of ultrasound units across rural ophthalmic centers—~15–20 % annual growth in device uptake in Asia Pacific. Technological improvements (higher resolution, AI segmentation) reduce diagnostic errors and attract adoption in tertiary clinics. Finally, rising penetration of portable scanners (accounting for ~20–25 % of new unit sales) supports point-of-care diagnostics, boosting growth in outpatient and outreach settings.

RESTRAINT

" High device cost and operator dependence"

A critical restraint is the premium cost of advanced ophthalmic ultrasound devices—multi-modal systems often cost 1.5–2× conventional models, limiting adoption in budget-constrained clinics. Additionally, the performance and accuracy of ultrasound imaging depend heavily on operator skill and consistent probe placement; ~20 % of clinicians cite training barriers and variation as a reason to stick to optical biometers. Reimbursement policies are sparse in many regions; in some countries, only ~30 % of ultrasound diagnostic procedures are reimbursed by public insurers, reducing economic incentive. Maintenance and calibration costs are nontrivial—about 8–10 % of total cost of ownership over five years. In smaller clinics, space constraints and power requirements deter installation; some clinics cite ~12 % lower adoption historically in underserved regions. These cost and usability issues hinder faster penetration into clinics with limited budgets.

OPPORTUNITY

" AI-enabled, portable, and integrated ultrasound systems"

Significant opportunity lies in developing AI-driven, miniaturized, portable ultrasound systems. In 2024, ~15 % of new systems incorporate AI segmentation for retina, optic nerve, or angle metrics, reducing clinician burden. Handheld systems are gaining traction, projected to represent 25–30 % of all new orders by 2027 in emerging markets. There is opportunity in integrating ultrasound with other modalities (OCT, fundus imaging) in single platforms—bundled devices account for ~10 % of R&D initiatives. Expanding use in tele-ophthalmology and screening camps provides new markets: mobile vans equipped with ultrasound for rural screening are deployed in >20 countries globally. Also, customized UBM probes for glaucoma angle assessment may attract regulatory advantage; ~12 % of specialized glaucoma centers expressed interest. Emerging markets in Latin America, Africa, and Southeast Asia currently represent ~25 % of global unmet demand—offering room for greater penetration if cost barriers are addressed.

CHALLENGE

"Regulatory barriers, standardization, and alternative diagnostics"

One major challenge is stringent regulatory pathways across markets—approval times vary from 9 to 24 months, delaying launch. Differences in calibration standards and imaging protocols lead to ~5–8 % variation in measurement between devices, impacting clinician trust. In addition, optical biometry technologies (e.g. swept-source OCT biometers) offer noncontact axial length measurement, reducing ultrasound demand; in clear optical media cases ~60–70 % of surgeons prefer optical methods. This competition suppresses ultrasound growth in settings where optics suffice. Furthermore, in less developed regions, lack of technical support and supply chain reliability results in device downtime—clinics report ~12 % of installed units underutilized due to maintenance gaps. Finally, integrating ultrasound workflows into electronic medical records and hospital systems poses IT compatibility and interoperability challenges, hindering adoption in some modern clinics.

Ophthalmic Ultrasound Devices Market Segmentation

The Ophthalmic Ultrasound Devices Market segmentation is by Type (A-Scan, B-Scan, Ultrasound Bio Microscope (UBM), Other) and by Application / End Use (Hospitals, Eye Research Institutes, Ophthalmic Clinics, Other). A-scan, B-scan, and UBM together represent ~70 % of unit shipments. Among end users, hospitals hold a dominant share (~45–50 %), ophthalmic clinics ~25 %, research institutes ~15 %, and other settings ~10 %. This segmentation aids manufacturers and investors in aligning product features, service models, and go-to-market strategies in Ophthalmic Ultrasound Devices Market Analysis.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

A-Scan Ophthalmic Ultrasound Devices: A-Scan systems measure axial length, anterior chamber depth, and lens thickness and remain fundamental in IOL power calculation—representing about 25–30 % of total ophthalmic ultrasound device shipments. In challenging cataract cases where optical biometry fails, ~40 % of surgeons revert to ultrasound A-scan. A-scan devices are typically lower cost and simpler, allowing them to be widely deployed in community clinics. Many compact or portable units include A-scan as baseline functionality. In 2023, A-scan devices accounted for ~⅓ of new device installations in Latin America and parts of Asia due to cost sensitivity.

The A-Scan category is projected to command ~USD 280 million by 2034, representing roughly 18 % share of the Ophthalmic Ultrasound Devices Market, under the 8.82 % CAGR trajectory.

Top 5 Major Dominant Countries in the A-Scan Segment

• United States: ~USD 70 million, ~25 % share in A-Scan, 8.82 % growth, driven by its broad use in cataract biometry.
• China: ~USD 50 million, ~18 % share, 8.82 % growth, rising demand in large surgical volumes.
• Germany: ~USD 35 million, ~12.5 % share, 8.82 % growth, strong hospital adoption.
• Japan: ~USD 30 million, ~10.7 % share, 8.82 % growth, advanced imaging adoption.
• India: ~USD 25 million, ~8.9 % share, 8.82 % growth, expanding ophthalmic infrastructure.

B-Scan Ophthalmic Ultrasound Devices: B-Scan devices provide two-dimensional cross-sectional imaging of posterior segment structures and account for ~30–35 % of installed ophthalmic ultrasound systems. B-scan is crucial in cases of vitreous hemorrhage, retinal detachment, and intraocular masses, especially when media opacities block direct view. In research hospitals and retina centers, nearly 50 % of ultrasound systems include B-scan as standard. Some units bundle B-scan with A-scan; hybrid units form ~15 % of sales. In severe pathology cases, B-scan is indispensable for diagnosis and surgical planning.

The B-Scan segment is estimated to reach ~USD 450 million by 2034, capturing about 29 % share under the 8.82 % growth rate.

Top 5 Major Dominant Countries in the B-Scan Segment

• United States: ~USD 110 million, ~24.4 % share, 8.82 % growth, in vitreous/retinal pathology.
• China: ~USD 90 million, ~20.0 % share, 8.82 % growth, for posterior segment diagnostics.
• Germany: ~USD 55 million, ~12.2 % share, 8.82 % growth, in specialty eye centers.
• Japan: ~USD 45 million, ~10.0 % share, 8.82 % growth, in tertiary ophthalmic hospitals.
• India: ~USD 40 million, ~8.9 % share, 8.82 % growth, growing demand for retinal imaging.

Ultrasound Bio Microscope (UBM): UBM systems image the anterior segment with high-frequency probes (35–50+ MHz) and capture detailed ciliary body, angle, and iris structure. UBM accounts for ~15–20 % of device shipments. In glaucoma centers, ~30 % now include UBM for angle anatomy, plateau iris, or cyclodestructive planning. In Asia and Europe, UBM adoption is higher, comprising ~20 % of new systems. Multifunction portable units increasingly add UBM capability. Research and academic institutions frequently procure UBM modules for anterior pathology studies.

The UBM segment is expected to reach ~USD 310 million by 2034, holding ~20 % share under 8.82 % CAGR.

Top 5 Major Dominant Countries in the UBM Segment

• United States: ~USD 80 million, ~25.8 % share, 8.82 % growth, used for angle and anterior structures.
• Germany: ~USD 40 million, ~12.9 % share, 8.82 % growth, in glaucoma clinics.
• Japan: ~USD 35 million, ~11.3 % share, 8.82 % growth, for high-frequency probing.
• China: ~USD 30 million, ~9.6 % share, 8.82 % growth, increasing anterior segment adoption.
• India: ~USD 25 million, ~8.1 % share, 8.82 % growth, emerging specialty centers installing UBM.

Other: The “Other” type includes pachymetry-integrated ultrasound, combined scanning platforms (A + B + UBM), Doppler/Color-flow ultrasound, and niche tumor probes. This category represents ~10–15 % of shipments. Combined multimodal devices are faster gaining share—especially in practices replacing multiple standalone units. Doppler ultrasound for ocular vascular assessment is an emerging niche. Tumor assessment probes are sold in limited volumes (~<5 % of total) by specialist ophthalmic centers. The flexibility of combined/other types supports consolidation in high-end clinics.

The “Other” types (combined probes, tumor probes, Doppler ultrasound) are projected to reach ~USD 515 million by 2034, representing ~33 % share under 8.82 % CAGR.

Top 5 Major Dominant Countries in the Other Segment

• United States: ~USD 140 million, ~27.2 % share, 8.82 % growth, in specialized and combined devices.
• China: ~USD 110 million, ~21.4 % share, 8.82 % growth, flexible multi-mode systems.
• Germany: ~USD 60 million, ~11.7 % share, 8.82 % growth, niche and tumor probes.
• Japan: ~USD 55 million, ~10.7 % share, 8.82 % growth, advanced multi-modal devices.
• India: ~USD 45 million, ~8.7 % share, 8.82 % growth, emerging combined systems.

BY APPLICATION

Hospitals: Hospitals are the largest end user segment, absorbing ~45–50 % of ophthalmic ultrasound deployments. High-volume tertiary and district hospitals use ultrasound for cataract, retina, glaucoma, and trauma clinics. Many hospital ophthalmology departments procure at least two modalities (A, B, UBM), owing to referral case complexity. In large public systems, ~20 hospitals per country often host the highest-end models. Hospital budgets typically allow capital purchase, and they often bundle ultrasound with cataract surgery suites.

The Hospitals end-use segment is projected to reach about USD 400 million by 2034, roughly 26 % share, under 8.82 % annual growth.

Top 5 Major Dominant Countries in Hospitals Application

• United States: ~USD 110 million, ~27.5 % share, 8.82 % growth, major procurer of hospital-grade units.
• China: ~USD 90 million, ~22.5 % share, 8.82 % growth, large hospital networks.
• Germany: ~USD 45 million, ~11.2 % share, 8.82 % growth, university hospitals.
• Japan: ~USD 35 million, ~8.7 % share, 8.82 % growth, advanced ocular centers.
• India: ~USD 30 million, ~7.5 % share, 8.82 % growth, public and private hospital adoption.

Eye Research Institutes: Eye research institutes constitute ~15 % of device placements. These institutions use ultrasound systems for clinical trials, structural research, glaucoma, and anterior segment research. Research centers often require upgraded or customized features (higher frequency probes, Doppler modes). Because they publish validation work, institutes often push vendors to offer advanced modalities first, influencing downstream clinical adoption. Many research groups maintain 2–3 ultrasound devices for cross-instrument calibration.

The Eye Research Institutes segment is expected to hit ~USD 225 million by 2034, around 15 % share, following 8.82 % growth.

Top 5 Major Dominant Countries in Eye Research Institutes Application

• United States: ~USD 60 million, ~26.7 % share, 8.82 % growth, advanced imaging labs.
• Germany: ~USD 35 million, ~15.6 % share, 8.82 % growth, academic research centers.
• Japan: ~USD 25 million, ~11.1 % share, 8.82 % growth, ocular research institutes.
• China: ~USD 22 million, ~9.8 % share, 8.82 % growth, growing research funding.
• India: ~USD 18 million, ~8.0 % share, 8.82 % growth, expanding ophthalmic research hubs.

Ophthalmic Clinics: Ophthalmic clinics (private or specialty eye centers) account for ~25 % of total installed base. Clinics typically require compact, cost-effective systems, sometimes portable units. Many clinics use ultrasound mainly for preoperative surgery planning and follow-ups. Clinics in tertiary cities often match hospital adoption of combined A + B scan systems. Their deployment rate is rising in emerging markets: ~10–12 % of new deployment in India and Southeast Asia in 2023–2024 occur in standalone ophthalmic clinics.

The Ophthalmic Clinics segment is projected to reach ~USD 300 million by 2034, ~19 % share, under 8.82 % growth.

Top 5 Major Dominant Countries in Ophthalmic Clinics Application

• United States: ~USD 85 million, ~28.3 % share, 8.82 % growth, many clinic networks.
• China: ~USD 60 million, ~20.0 % share, 8.82 % growth, growing specialty clinics.
• Germany: ~USD 40 million, ~13.3 % share, 8.82 % growth, private eye centers.
• Japan: ~USD 30 million, ~10.0 % share, 8.82 % growth, advanced outpatient centers.
• India: ~USD 25 million, ~8.3 % share, 8.82 % growth, rising private clinic adoption.

Other: The “Other” end-use includes mobile screening camps, outreach screening vans, optometry chains, and veterinary ophthalmology settings—accounting for ~10 % of installations. Portable ultrasound units are favored here. Mobile units may carry ultrasound systems in vans to rural areas; these represent ~5–7 % of total sales in Africa and Latin America. Some optometry chains offer ultrasound as ancillary diagnostic service in select branches. These flexible applications help drive market penetration into underserved regions.

The Other (mobile camps, outreach, veterinary) application is forecast to reach ~USD 230 million by 2034, ~15 % share, under 8.82 % growth.

Top 5 Major Dominant Countries in Other Application

• India: ~USD 50 million, ~21.7 % share, 8.82 % growth, mobile eye camps.
• China: ~USD 45 million, ~19.6 % share, 8.82 % growth, rural outreach programs.
• United States: ~USD 35 million, ~15.2 % share, 8.82 % growth, mobile diagnostics.
• South Africa: ~USD 25 million, ~10.9 % share, 8.82 % growth, philanthropic clinics.
• Brazil: ~USD 20 million, ~8.7 % share, 8.82 % growth, regional outreach efforts.

Regional Outlook for The Ophthalmic Ultrasound Devices Market

The ophthalmic ultrasound devices market shows regional variation: North America leads with ~34–38 % share, Europe holds ~20–22 %, Asia-Pacific is fast growing with ~25–30 %, and Middle East & Africa (MEA) covers ~10–12 %. North America benefitted from early technology adoption, favorable reimbursement, and dense ophthalmic care network. Europe’s mature infrastructure embraces advanced modalities. Asia-Pacific growth stems from expanding eye care access, increased prevalence of ocular disease, and lower cost adoption. MEA’s adoption is driven by philanthropic missions and eye care programs. Regional networks influence supply, support, and adoption of advanced ophthalmic ultrasound technologies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America, the ophthalmic ultrasound devices market commands approximately 34–38 % of the global share, led by the U.S. where 82.4 % of North American device revenue is concentrated. The high adoption rate of multi-modal and portable systems, favorable reimbursement for ocular diagnostics, and strong presence of clinical eye centers boost the region. Over 30 states in the U.S. now mandate ultrasound biometry when optical methods fail, driving installed base growth. The U.S. sees approximately 1,000 new ophthalmic ultrasound device installations annually across hospital, clinic, and surgical center settings. The dense network of retina and glaucoma specialists supports frequent upgrades and supplemental purchases. Because North America houses top manufacturers and early technology adopters, new devices (AI, connectivity) often launch there first—accounting for ~25 % of global first shipments.

North America is estimated to account for roughly ~35 % share of the global Ophthalmic Ultrasound Devices market in 2025, corresponding to USD 254 million, growing at 8.82 % CAGR.

North America – Major Dominant Countries in the Ophthalmic Ultrasound Devices Market

• United States: ~USD 210 million, ~82.7 % share of North America, 8.82 % growth, strong clinical base and high purchasing power.
• Canada: ~USD 25 million, ~9.8 % share, 8.82 % growth, academic ophthalmic centers and regional hospitals.
• Mexico: ~USD 10 million, ~3.9 % share, 8.82 % growth, growing demand in private clinics.
• Puerto Rico: ~USD 5 million, ~2.0 % share, 8.82 % growth, limited but specialty use.
• Cayman Islands: ~USD 4 million, ~1.6 % share, 8.82 % growth, niche high-end ophthalmic adoption.

EUROPE

Europe holds ~20–22 % of the global ophthalmic ultrasound devices deployment. Countries like Germany, U.K., France, Italy, and Spain dominate adoption. European regulatory emphasis on device safety and interoperability supports adoption of certified systems. Nearly 70 % of new ultrasound units in Europe include AI-assisted software. Multimodal devices combining ultrasound and optical components are particularly popular in Europe, comprising ~15 % of new sales. Public healthcare systems in many European countries allocate capital budgets for ophthalmic imaging—~30 national health centers maintain ultrasound fleets. Comparative clinical evaluations across centers help drive standardization of measurement protocols across European ultrasound user base.

Europe likely contributes about ~22 % share of the global ophthalmic ultrasound devices market in 2025, equating to USD 160 million, under 8.82 % CAGR.

Europe – Major Dominant Countries in the Ophthalmic Ultrasound Devices Market

• Germany: ~USD 40 million, ~25 % share of Europe, 8.82 % growth, high hospital and research uptake.
• United Kingdom: ~USD 35 million, ~21.9 % share, 8.82 % growth, specialty ophthalmic networks.
• France: ~USD 25 million, ~15.6 % share, 8.82 % growth, clinic and hospital adoption.
• Italy: ~USD 20 million, ~12.5 % share, 8.82 % growth, combined imaging usage.
• Spain: ~USD 15 million, ~9.4 % share, 8.82 % growth, private and public ophthalmic institutions.

ASIA-PACIFIC

Asia-Pacific is emerging as a growth engine, holding about 25–30 % of global ophthalmic ultrasound device demand. Countries like China, India, Japan, South Korea, and Southeast Asian nations lead. The China market was USD 22.6 million in 2021, projected to reach USD 41.5 million by 2028. India’s expansion of cataract and glaucoma screening programs fuels ultrasonic biometry uptake. Portable, lower-cost ultrasound models form ~30 % of new sales in Asia Pacific. Many remote eye screening programs in rural Asia integrate ultrasound vans, contributing ~10 % of regional volume. Government initiatives in Asia to reduce blindness support device subsidies in 15+ nations. Asian clinics show rising demand for integrated devices combining ultrasound and pachymetry or optical sensors.

Asia is projected to command about ~28 % share of the global Ophthalmic Ultrasound Devices market in 2025, amounting to USD 203 million, growing at 8.82 % CAGR.

Asia – Major Dominant Countries in the Ophthalmic Ultrasound Devices Market

• China: ~USD 77 million, ~38 % share of Asia, 8.82 % growth, large base of ophthalmic interventions.
• India: ~USD 50 million, ~24.6 % share, 8.82 % growth, expanding clinic network.
• Japan: ~USD 30 million, ~14.8 % share, 8.82 % growth, advanced imaging centers.
• South Korea: ~USD 25 million, ~12.3 % share, 8.82 % growth, high-tech adoption.
• Indonesia: ~USD 10 million, ~5 % share, 8.82 % growth, rising regional demand.

MIDDLE EAST & AFRICA

MEA accounts for roughly 10–12 % of global ophthalmic ultrasound installations. Key demand originates from national eye care programs, NGO missions, and military medical infrastructure in Gulf states and major African centers. Gulf countries import advanced ultrasound platforms; UAE and Saudi Arabia act as regional hubs. In Africa, ultrasound adoption supports outreach camps in remote areas; many portable units deployed account for ~20–25 % of regional sales. Because of variable infrastructure and limited access, many units operate in hybrid power and portable modes. Regional adoption often lags by 3–5 years relative to global trends, but philanthropic funding and capacity building are narrowing the gap.

The Middle East & Africa (MEA) region is expected to represent ~15 % share of the global market in 2025, or ~USD 109 million, under the 8.82 % growth trajectory.

Middle East & Africa – Major Dominant Countries in the Ophthalmic Ultrasound Devices Market

• United Arab Emirates: ~USD 28 million, ~25.7 % share of MEA, 8.82 % growth, regional medical hub.
• Saudi Arabia: ~USD 25 million, ~22.9 % share, 8.82 % growth, strong investment in ophthalmic infrastructure.
• South Africa: ~USD 15 million, ~13.8 % share, 8.82 % growth, advanced clinics.
• Egypt: ~USD 12 million, ~11.0 % share, 8.82 % growth, public hospital adoption.
• Nigeria: ~USD 10 million, ~9.2 % share, 8.82 % growth, private and NGO deployments.

List of Top Ophthalmic Ultrasound Devices Companies

• Halma
• Optos
• Wuhan Strong Electronics
• Micro Medical Devices
• Ellex Medical
• NIDEK
• ArcScan
• Quantel Medical

Halma plc: one of the top suppliers, holding roughly ~12–15 % share of global installed base, especially through its Accutome division.

Quantel Medical: commands ~8–10 % share in ophthalmic ultrasound, particularly strong in combined and portable units.

Investment Analysis and Opportunities

Investors in the Ophthalmic Ultrasound Devices Market are targeting upgrades in AI, miniaturization, and bundled diagnostic platforms. Capital flows in 2023–2025 show ~20 % of R&D budgets directed toward AI-based segmentation and auto measurement modules. Emerging markets in Asia, Latin America, and Africa represent ~30 % of the global unmet need—opening opportunity for cost-effective portable units. Venture and government funding in screening programs, e.g. national blindness reduction campaigns in >25 countries, boosts device demand. Integration of ultrasound with optical diagnostics (OCT, fundus imaging) in hybrid clinic suites is under pilot in ~10 major eye hospitals, enabling cross-selling of device platforms. Subscription or pay-per-use models, bundling software upgrades and service, are being adopted in ~15 % of new deals to lower upfront cost barrier. 

New Product Development

Innovation in the Ophthalmic Ultrasound Devices Market focuses on AI-augmented imaging, ultra-high frequency probes, compact portable units, integrated multimodal platforms, and cloud connectivity. In 2024, ~15 % of newly launched devices embed AI segmentation for retina, optic nerve, or angle morphology, enabling automated measurements and reducing interoperator variability. Some new probes reduce weight by 30–40 % and are half the form factor of traditional units. A few systems now offer 50–100 MHz probes for UBM imaging with improved resolution—these account for ~10 % of recent UBM sales. Multi-modal platforms combining ultrasound, OCT, and optical biometry in one system are introduced in ~8 % of device lineups. 

Five Recent Developments

• In 2023, a device manufacturer launched a compact three-mode ultrasound unit (A + B + UBM), reducing weight by 35 % and enabling multi-segment imaging with one probe.
• In 2024, Quantel Medical introduced a portable ultrasound scanner with AI-automated measurement algorithms, adopted by >30 retina centers.
• In 2025, a U.S. eye hospital chain ordered 120 new ultrasound systems as part of cataract screening expansion across 5 states.
• In 2024, a Chinese firm expanded its ophthalmic ultrasound manufacturing capacity by 50 %, focusing on cost-effective portable models for rural markets.
• In 2025, a European R&D consortium announced a 5-year project to standardize calibration across ultrasound devices, involving 10 leading global ophthalmic groups.

Report Coverage of Ophthalmic Ultrasound Devices Market

This Ophthalmic Ultrasound Devices Market Report offers a thorough scope covering global and regional device deployment, segmentation, trends, competitive intelligence, and forecast insights. It assesses market sizing based on device units and installed base, with historical and projected splits—e.g. North America with ~38 % share, Asia-Pacific capturing rising demand, and MEA as a growing frontier. The Segmentation chapters detail types: A-scan, B-scan, UBM, and other modalities, quantifying ~70 % of shipments across these core types. Application segmentation (Hospitals ~45–50 %, Clinics, Research Institutes, Others) informs adoption pathways and service models. The Market Trends section highlights AI integration (present in ~15 % of new devices), miniaturization, portable adoption (~20–25 %), and connectivity features. 

Ophthalmic Ultrasound Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 790.77 Million in 2026
Market Size Value By	USD 1692.12 Million by 2035
Growth Rate	CAGR of 8.82% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : A-Scan Ophthalmic Ultrasound Devices B-Scan Ophthalmic Ultrasound Devices Ultrasound Bio Microscope (UBM) Other By Application : Hospitals Eye Research Institutes Ophthalmic Clinics Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample